349 related articles for article (PubMed ID: 23472659)
1. The oncogene eIF4E: using biochemical insights to target cancer.
Carroll M; Borden KL
J Interferon Cytokine Res; 2013 May; 33(5):227-38. PubMed ID: 23472659
[TBL] [Abstract][Full Text] [Related]
2. Signalling to eIF4E in cancer.
Siddiqui N; Sonenberg N
Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
[TBL] [Abstract][Full Text] [Related]
3. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
Piserà A; Campo A; Campo S
J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
6. eIF4E Phosphorylation in Prostate Cancer.
D'Abronzo LS; Ghosh PM
Neoplasia; 2018 Jun; 20(6):563-573. PubMed ID: 29730477
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic initiation factor 4E (eIF4E): A recap of the cap-binding protein.
Batool A; Aashaq S; Andrabi KI
J Cell Biochem; 2019 Sep; 120(9):14201-14212. PubMed ID: 31074051
[TBL] [Abstract][Full Text] [Related]
9. The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.
Karaki S; Andrieu C; Ziouziou H; Rocchi P
Adv Protein Chem Struct Biol; 2015; 101():1-26. PubMed ID: 26572974
[TBL] [Abstract][Full Text] [Related]
10. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
[TBL] [Abstract][Full Text] [Related]
11. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
[TBL] [Abstract][Full Text] [Related]
12. Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly.
Frosi Y; Usher R; Lian DTG; Lane DP; Brown CJ
BMC Biol; 2019 May; 17(1):40. PubMed ID: 31118010
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP.
Topisirovic I; Siddiqui N; Lapointe VL; Trost M; Thibault P; Bangeranye C; Piñol-Roma S; Borden KL
EMBO J; 2009 Apr; 28(8):1087-98. PubMed ID: 19262567
[TBL] [Abstract][Full Text] [Related]
14. Initiation of mRNA translation in oncogenesis: the role of eIF4E.
Montanaro L; Pandolfi PP
Cell Cycle; 2004 Nov; 3(11):1387-9. PubMed ID: 15492504
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
Kosciuczuk EM; Saleiro D; Platanias LC
Cytokine; 2017 Jan; 89():116-121. PubMed ID: 27094611
[TBL] [Abstract][Full Text] [Related]
16. The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.
Osborne MJ; Borden KL
Immunol Rev; 2015 Jan; 263(1):210-23. PubMed ID: 25510279
[TBL] [Abstract][Full Text] [Related]
17. Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.
Topisirovic I; Siddiqui N; Orolicki S; Skrabanek LA; Tremblay M; Hoang T; Borden KL
Mol Cell Biol; 2009 Mar; 29(5):1152-62. PubMed ID: 19114552
[TBL] [Abstract][Full Text] [Related]
18. Mnks, eIF4E phosphorylation and cancer.
Proud CG
Biochim Biophys Acta; 2015 Jul; 1849(7):766-73. PubMed ID: 25450520
[TBL] [Abstract][Full Text] [Related]
19. eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase.
Sundin T; Peffley D; Hentosh P
Exp Cell Res; 2013 Aug; 319(13):2103-2112. PubMed ID: 23747720
[TBL] [Abstract][Full Text] [Related]
20. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.
Culjkovic B; Topisirovic I; Borden KL
Cell Cycle; 2007 Jan; 6(1):65-9. PubMed ID: 17245113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
